Your browser doesn't support javascript.
loading
Trends in mortality in people with HIV from 1999 to 2020: a multi-cohort collaboration.
Tusch, Erich; Ryom, Lene; Pelchen-Matthews, Annegret; Mocroft, Amanda; Elbirt, Daniel; Oprea, Cristiana; Günthard, Huldrych F; Staehelin, Cornelia; Zangerle, Robert; Suarez, Isabelle; Vehreschild, Jörg Janne; Wit, Ferdinand; Menozzi, Marianna; d'Arminio Monforte, Antonella; Spagnuolo, Vincenzo; Pradier, Christian; Carlander, Christina; Suanzes, Paula; Wasmuth, Jan-Christian; Carr, Andrew; Petoumenos, Kathy; Borgans, Frauke; Bonnet, Fabrice; De Wit, Stephane; El-Sadr, Wafaa; Neesgaard, Bastian; Jaschinski, Nadine; Greenberg, Lauren; Hosein, Sean R; Gallant, Joel; Vannappagari, Vani; Young, Lital; Sabin, Caroline; Lundgren, Jens; Peters, Lars; Reekie, Joanne.
Afiliación
  • Tusch E; CHIP, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Ryom L; CHIP, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Pelchen-Matthews A; Department of Infectious Diseases, Hvidovre University Hospital, Copenhagen, Denmark.
  • Mocroft A; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Elbirt D; Centre for Clinical Research, Epidemiology, Modelling and Evaluation (CREME), Institute for Global Health, University College London, London, UK.
  • Oprea C; CHIP, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Günthard HF; Centre for Clinical Research, Epidemiology, Modelling and Evaluation (CREME), Institute for Global Health, University College London, London, UK.
  • Staehelin C; Allergy, Immunology and HIV Unit, Kaplan Medical Center, Rehovot, Israel.
  • Zangerle R; Victor Babes Clinical Hospital for Infectious and Tropical Diseases, Bucharest, Romania.
  • Suarez I; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich.
  • Vehreschild JJ; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
  • Wit F; Department of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Menozzi M; Austrian HIV Cohort Study (AHIVCOS), Medizinische Universität Innsbruck, Innsbruck, Austria.
  • d'Arminio Monforte A; University Hospital Cologne, Cologne, Germany.
  • Spagnuolo V; University Hospital Cologne, Cologne, Germany.
  • Pradier C; AIDS Therapy Evaluation in the Netherlands (ATHENA) cohort, HIV Monitoring Foundation, Amsterdam, the Netherlands.
  • Carlander C; Modena HIV Cohort, Università degli Studi di Modena, Modena, Italy.
  • Suanzes P; Italian Cohort Naive Antiretrovirals (ICONA), ASST Santi Paolo e Carlo, Milano, Italy.
  • Wasmuth JC; IRCCS San Raffaele Scientific Institute, Milano, Italy.
  • Carr A; Nice HIV Cohort, Université Côte d'Azur et Centre Hospitalier Universitaire, Nice, France.
  • Petoumenos K; Swedish InfCare HIV Cohort, Karolinska University Hospital, Sweden.
  • Borgans F; Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Bonnet F; University Hospital Bonn, Bonn, Germany.
  • De Wit S; HIV and Immunology Unit, St Vincent's Hospital, Sydney, Australia.
  • El-Sadr W; The Australian HIV Observational Database (AHOD), UNSW, Sydney, Australia.
  • Neesgaard B; Frankfurt HIV Cohort Study, Goethe-University Hospital, University Hospital, Department of Internal Medicine, Infectious Diseases, Germany.
  • Jaschinski N; University of Bordeaux, National Institute for Health and Medical Research (INSERM) UMR 1219, Research Institute for Sustainable Development (IRD) EMR 271, Bordeaux Population Health Centre & CHU de Bordeaux, Saint-André Hospital, Service de Médecine Interne et Maladies Infectieuses,  Bordeaux,
  • Greenberg L; Department of Infectious Diseases, St Pierre University Hospital, Brussels, Belgium.
  • Hosein SR; Mailman School of Public Health, Columbia University, New York, USA.
  • Gallant J; CHIP, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Vannappagari V; CHIP, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Young L; CHIP, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Sabin C; European AIDS Treatment Group (EATG), Brussels, Belgium.
  • Lundgren J; Gilead Sciences, Foster City, California, USA.
  • Peters L; ViiV Healthcare, Research Triangle Park, North Carolina, USA.
  • Reekie J; Merck Sharp & Dohme, Rahway, New Jersey, USA.
Clin Infect Dis ; 2024 Apr 26.
Article en En | MEDLINE | ID: mdl-38663013
ABSTRACT

BACKGROUND:

Mortality among people with HIV declined with the introduction of combination antiretroviral therapy. We investigated trends over time in all-cause and cause-specific mortality in people with HIV from 1999-2020.

METHODS:

Data were collected from the DAD cohort from 1999 through January 2015 and RESPOND from October 2017 through 2020. Age-standardized all-cause and cause-specific mortality rates, classified using Coding Causes of Death in HIV (CoDe), were calculated. Poisson regression models were used to assess mortality trends over time.

RESULTS:

Among 55716 participants followed for a median of 6 years (IQR 3-11), 5263 participants died (crude mortality rate [MR] 13.7/1000 PYFU; 95%CI 13.4-14.1). Changing patterns of mortality were observed with AIDS as the most common cause of death between 1999- 2009 (n = 952, MR 4.2/1000 PYFU; 95%CI 4.0-4.5) and non-AIDS defining malignancy (NADM) from 2010 -2020 (n = 444, MR 2.8/1000 PYFU; 95%CI 2.5-3.1). In multivariable analysis, all-cause mortality declined over time (adjusted mortality rate ratio [aMRR] 0.97 per year; 95%CI 0.96, 0.98), mostly from 1999 through 2010 (aMRR 0.96 per year; 95%CI 0.95-0.97), and with no decline shown from 2011 through 2020 (aMRR 1·00 per year; 95%CI 0·96-1·05). Mortality due all known causes except NADM also declined over the entire follow-up period.

CONCLUSION:

Mortality among people with HIV in the DAD and/or RESPOND cohorts decreased between 1999 and 2009 and was stable over the period from 2010 through 2020. The decline in mortality rates was not fully explained by improvements in immunologic-virologic status or other risk factors.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2024 Tipo del documento: Article País de afiliación: Dinamarca

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2024 Tipo del documento: Article País de afiliación: Dinamarca
...